Plasma levels of vascular endothelial growth factor (VEGF) are predictive of disease-progression in B-cell chronic lymphocytic leukemia (B-CLL).

被引：0
|
作者：
Maurillo, L [1 ]
Del Poeta, G [1 ]
Venditti, A [1 ]
Giovanna, S [1 ]
Buccisano, F [1 ]
Del Principe, MI [1 ]
Tamburini, A [1 ]
Scornajenghi, A [1 ]
Epiceno, AM [1 ]
Piccioni, D [1 ]
Amadori, S [1 ]
机构：
[1] Univ Roma Tor Vergata, I-00173 Rome, Italy
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1517
引用
收藏
页码：360A / 360A
页数：1
相关论文
共 50 条
  • [31] VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INCREASES CELL MIGRATION THROUGH INTERACTION WITH THE CXCR4/SDF1 AXIS IN BCELL CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL)
    Ballester Garcia, S.
    Eroles Asensio, P.
    Perez Martinez, A.
    Tormo Martin, E.
    Pineda Merlo, B.
    Navarro Cubells, B.
    Teruel Casasus, A.
    Solano Vercet, C.
    Treol Castera, M. J.
    HAEMATOLOGICA, 2014, 99 : 43 - 44
  • [32] MECHANISMS OF LEUKEMIC-CELL GROWTH IN HAIRY-CELL LEUKEMIA (HCL) AND B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) PATIENTS
    TRENTIN, L
    ZAMBELLO, R
    BULIAN, P
    CERUTTI, A
    MILANI, A
    ENTHAMMER, C
    ADAMI, F
    AGOSTINI, C
    SEMENZATO, G
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A200 - A200
  • [33] CONTROL OF B-LYMPHOCYTE PROLIFERATION BY TRANSFORMING GROWTH-FACTOR-BETA (TGF-B) IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
    LAGNEAUX, L
    DELFORGE, A
    BRON, D
    STRYCKMANS, P
    BLOOD, 1994, 84 (10) : A526 - A526
  • [34] The significance of soluble HLA-G plasma levels as well as messenger HLA-G for B-cell chronic lymphocytic leukemia (B-CLL)
    Giannopoulos, K.
    Schmitt, M.
    Kowal, M.
    Wlasiuk, P.
    Bojarska-Junak, A.
    Rolinski, J.
    Dmoszynska, A.
    LEUKEMIA RESEARCH, 2008, 32 (12) : 1815 - 1819
  • [35] Allogeneic stem cell transplantation for chronic lymphocytic leukemia (B-CLL).
    Pavletic, ZS
    Bierman, PJ
    Tarantolo, SR
    Vose, JM
    Wu, D
    Reed, EC
    Pierson, JL
    Lynch, J
    Kessinger, A
    Armitage, JO
    Bishop, MR
    BLOOD, 1997, 90 (10) : 4508 - 4508
  • [36] Serum levels of syndecan-1 in B-cell chronic lymphocytic leukemia: Correlation with the extent of angiogenesis and disease-progression risk in early disease
    Molica, Stefano
    Vitelli, Gaetano
    Mirabelli, Rosanna
    Digiesu, Giovanna
    Giannarelli, Diana
    Cuneo, Antonio
    Ribatti, Domenico
    Vacca, Angelo
    LEUKEMIA & LYMPHOMA, 2006, 47 (06) : 1034 - 1040
  • [37] Allogeneic stem cell transplantation from related or unrelated donors for B-cell chronic lymphocytic leukemia (B-CLL).
    Pavletic, ZS
    Arrowsmith, ER
    Bierman, PJ
    Goodman, SA
    Vose, JM
    Tarantolo, SR
    Stein, RS
    Greer, JP
    Kollath, JP
    Weisenburger, DD
    Wolff, SN
    Armitage, JO
    Bishop, MR
    BLOOD, 1998, 92 (10) : 288A - 288A
  • [38] Alterations of human requiem gene in B cell chronic lymphocytic leukemia (B-CLL)
    Zhu, SG
    Davis, R
    Chiorazzi, N
    Schroeder, HW
    FASEB JOURNAL, 2002, 16 (04): : A347 - A347
  • [39] Reconstitution of the T cell repertoire following treatment with alemtuzumab in patients with B-cell chronic lymphocytic leukemia (B-CLL).
    Rezvany, MR
    Tehrani, MJ
    Karlsson, C
    Lundin, J
    Rabbani, H
    Mellstedt, K
    Österborg, A
    BLOOD, 2005, 106 (11) : 837A - 837A
  • [40] Toll like receptors (TLRs) in B cell chronic lymphocytic leukemia (B-CLL).
    Manoussaka, MS
    Memon, A
    Nathwani, A
    Porakishvili, N
    Clark, E
    Lydyard, PM
    BLOOD, 2005, 106 (11) : 326B - 326B
12345